Neuroblate Robotic Probe Driver
Payments companies reported to CMS as associated with Neuroblate Robotic Probe Driver. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuroblate Robotic Probe Driver, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuroblate Robotic Probe Driver
These are the largest totals companies reported as associated with Neuroblate Robotic Probe Driver. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Weinreich | Fort Collins, CO | Interventional Cardiology | $697.04 |
| Frank Corrigan | Atlanta, GA | Interventional Cardiology | $645.64 |
| Gregory Fontana | Thousand Oaks, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $354.90 |
| Patrick Hu | Riverside, CA | Cardiovascular Disease | $88.42 |
| Matthew Price | La Jolla, CA | Interventional Cardiology | $86.12 |
| Brian Jefferson | Nashville, TN | Interventional Cardiology | $84.81 |
| Samuel Horr | Nashville, TN | Interventional Cardiology | $53.07 |
| Sameer Arora | Hiram, GA | Interventional Cardiology | $52.81 |
| Abdul Sheikh | Hiram, GA | Interventional Cardiology | $52.81 |
| Andrew Goodman | Nashville, TN | Interventional Cardiology | $35.27 |
Prescribed Neuroblate Robotic Probe Driver?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.